Indeterminate lung nodules in cancer patients: Pretest probability of malignancy and the role of18F-FDG PET/CT

American Journal of Roentgenology

Volumn 202, Issue 3, 2014, Pages 507-514

  Evangelista, Laura ^a   Panunzio, Annalori ^a   Polverosi, Roberta ^b   Pomerri, Fabio ^a   Rubello, Domenico ^c  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Unit for the Diagnosis and Therapy of Osteoporosis   (Italy)

^c Rovigo Hospital   (Italy)

Author keywords

CT; Lung nodules; PET CT; Probability of malignancy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL;

ADULT; AGED; ARTICLE; CANCER RISK; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VERY ELDERLY;

AGED; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896701643     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11728     Document Type: Article

References (34)

1. Lillington GA. Management of solitary pulmonary nodules: how to decide when resection is required. Postgrad Med 1997; 101:145-150
2. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med 1997; 157:849-855 (Pubitemid 28337035)
3. Gould MK, Ananth L, Barnett PG; Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007; 131:383-388 (Pubitemid 46280396)
4. Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax 2008; 63:335-341 (Pubitemid 351497946)
5. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(suppl 3):108S-130S (Pubitemid 47502803)
6. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 2000; 27:1441-1456
7. 18F-fluorodeoxyglucose positron emission tomography. Chest 2005; 128:2490-2496
8. Lillington GA, Caskey CI. Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1993; 14:111-119 (Pubitemid 23098992)
9. Ginsberg MS, Griff SK, Go BD, et al. Pulmonary nodules resected at video-assisted thoracoscopic surgery: etiology in 426 patients. Radiology 1999; 213:277-282 (Pubitemid 29470438)
10. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009; 50:11S-20S
11. 18F- fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging 2010; 37:1087-1094
12. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009; 150:795-802
13. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172 (Pubitemid 351193639)
14. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008; 54:17-23 (Pubitemid 351182592)
15. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993; 186:405-413 (Pubitemid 23033864)
16. Black WC, Armstrong P. Communicating the significance of radiologic test results: the likelihood ratio. AJR 1986; 147:1313-1318 (Pubitemid 17185053)
17. Beigelman-Aubry C, Hill C, Grenier PA. Management of an incidentally discovered pulmonary nodule. Eur Radiol 2007; 17:449-466 (Pubitemid 46140316)
18. Huston J 3rd, Muhm JR. Solitary pulmonary opacities: plain tomography. Radiology 1987; 163:481-485 (Pubitemid 17068930)
19. Lillington GA. Pulmonary nodules: solitary and multiple. Clin Chest Med 1982; 3:361-367 (Pubitemid 13249184)
20. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using flu-orine- 18-FDG and PET. J Nucl Med 1996; 37:943-948 (Pubitemid 126447126)
21. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003; 348:2535-2542 (Pubitemid 36712195)
22. Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007; 48:214-220 (Pubitemid 47555346)
23. Luce JA. Metastatic and malignant tumors. In: Murray JF, Nadel J, eds. Textbook of respiratory medicine, 3rd ed. Philadelphia, PA: Saunders, 2000:1470
24. Weiss L, Gilbert HA. Pulmonary metastasis. Boston, MA: GK Hall, 1978
25. Quint LE, Park CH, Iannettoni MD. Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology 2000; 217:257-261 (Pubitemid 33097611)
26. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006; 82:1016-1020
27. Pomerri F, Pucciarelli S, Maretto I, et al. Significance of pulmonary nodules in patients with colorectal cancer. Eur Radiol 2012; 22:1680-1686
28. Hellwig D, Baum RP, Kirsch CM. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin 2009; 48:59-69
29. Alberts WM. Diagnosis and management of lung cancer executive summary: ACCP evidencebased clinical practice guidelines (2nd edition). Chest 2007; 132(suppl 3):1S-19S (Pubitemid 47502795)
30. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003; 138:724-735 (Pubitemid 38139236)
31. Fischer BM, Mortensen J, Højgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001; 2:659-666 (Pubitemid 33085811)
32. Goldsmith SJ, Kostakoglu L. Nuclear medicine imaging of lung cancer. Radiol Clin North Am 2000; 38:511-524 (Pubitemid 30350450)
33. Apostolova I, Wiemker R, Paulus T, et al. Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT. Eur Radiol 2010; 20:1868-1877
34. Boellaard R, Buijs F, de Jong HW, et al. Characterization of a single LSO crystal layer high resolution research tomograph. Phys Med Biol 2003; 48:429-448 (Pubitemid 36322037)